Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: For 3 months ending Feb 28

For 3 months ending Feb 28

posted on Apr 20, 2007 12:45PM
The Company’s investment in the joint venture for the three months ended February 28, 2007 provided income after expenses in the amount of approximately $11,657,000 resulting from licensing agreements for our intellectual property with Lexmark, Schneider Electric, NEC Corporation and its selected subsidiaries and Funai Electric for one time payments. The Company’s investment in the joint venture provided net income after expenses in the amount of approximately $29,328,000 for the three months ended February 28, 2006.
Share
New Message
Please login to post a reply